30
Participants
Start Date
October 7, 2025
Primary Completion Date
October 7, 2026
Study Completion Date
January 1, 2027
MuscleSCS
"The population for this study will include two specific groups of the same pain population. Group one is the Pre-existing SCS Group, these are pain patients with chronic back pain, and who have been implanted with an SCS system with a percutaneous lead or a paddle lead and BurstDRTM IPG for more than 6 month and having success with their BurstSCS stimulation (\>50% pain relief).~Group two is the Trial SCS Group, these are pain patients with chronic back pain, and who have been determined to be candidates for trial and potential permanent SCS with a percutaneous lead or a paddle lead and BurstDRTM IPG."
RECRUITING
WVUM/Thomas Hospitals (Saint Francis Hospital) Spine and Nerve Center, Charleston
Collaborators (1)
Abbott Medical Devices
INDUSTRY
Saint Francis Hospital
OTHER